On 22 May 2025, Sun Pharmaceutical announced the appointment of Ms. Vidhi Shanghvi as Whole-time Director, the retirement of Mr. Sudhir Valia, approval of audited financial results, and a final dividend of Rs. 5.50 per share, with the 33rd AGM scheduled for 31 July 2025.